# A Study of SYHA1805 in Healthy Adult Subjects

> **NCT04645901** · PHASE1 · UNKNOWN · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Drug: SYHA1805 tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04645901
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2022-05
- **Final completion:** 2022-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04645901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04645901, "A Study of SYHA1805 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04645901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*